
Vektor Medical, Inc.
- Home
- Companies
- Vektor Medical, Inc.
- News
- The feasibility of using vMap in ...
The feasibility of using vMap in patients after COVID-19 Infection presented at THRS 2021.
Mar. 31, 2021
Courtesy ofVektor Medical, Inc.
COVID-19 is associated with myocardial inflammation which may cause or exacerbate arrhythmias. A study led by Dr. David Krummen was presented at the Taiwan Heart Rhythm Society - Cutting-Edge Care for Heart Rhythm on April 17-18, 2021. The study reports that use of vMap™ computational 12-lead ECG analysis was able to provide arrhythmia insights beyond those available from a standard 12-lead ECG in patients following COVID-19 infection.
Stay in the loop!
Select your areas of interest to receive industry updates.